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background: The United States is rapidly moving to implement public quality reporting and value-based purchasing for physicians. The 
properties of the performance measures used in these programs, however, are not well understood. Medicare currently allows physicians 
to select from a list of measures to report. We evaluated how subsets of quality measures, for which cardiology practices may choose to 
report, reflect quality as assessed by a broader collection of measures.
Methods: Using the National Cardiovascular Data Registry® PINNACLE Registry®, we evaluated performance by cardiology practices in 
2013 on 18 pre-defined ambulatory quality measures: 9 for coronary artery disease (CAD), 6 for heart failure (HF), 2 for atrial fibrillation 
(AFIB), and 1 measure of hypertension management. After excluding patients with contraindications for each measure, we calculated 
practice level rates of successfully achieving the quality measures. We compared rates for CAD, HF, and AFIB to the overall measure.
Results: Amongst the 1,566,451 patients with 3,098,541 office visits in 149 practices, 986,512 (79.9%) had HTN, 695,975 (54.0%) 
had CAD, 301,549 (24.9%) had AFIB, and 288,119 (22.6%) had HF. The practices’ performance ranged from 97.3% (± 1 SD of 5.2) for 
symptom management in HF to 6.6% (±10.3) for cardiac rehabilitation referral in CAD. The mean performance was 53.3% (±11.9) for the 
composite of all 18 measures, 52.0% (±12.5) for CAD, 56.6% (±14.5) for HF, and 38.1% (±16.5) for AFIB measures. When comparing the 
disease-specific composites to the overall composite, the correlation coefficients were 0.88 for CAD, 0.82 for HF, and 0.44 for AFIB.
conclusion: In cardiology practices, selected quality measures vary in reflecting overall quality performance. While the tight correlation 
for CAD measures with the composite may be because those are half of the overall measures, the HF measures represent only one third 
and have similarly high correlation. However, AFIB measures performed the poorest, driven by 1 of the 2 measures being particularly low. 
In assessing quality performance though limited measure sets, further guidance is needed to select those measures that best reflect a 
practice’s quality performance.
